Title: [Antisense constructs, therapeutics of the future?]
Authors: Van Aerschot, Arthur # ×
Issue Date: Jan-2000
Series Title: Verhandelingen - Koninklijke Academie voor Geneeskunde van België vol:62 issue:6 pages:565-601
Abstract: Two lines of research were followed to obtain an adequate antisense effect. Natural oligonucleotides can degrade their mRNA targets catalytically, but are prone to enzymatic instability. Therefore, we looked for the minimal molecular modification, which would yield nuclease stable constructs, which can be taken up sufficiently to exert a selective antiproliferative effect. Small aliphatic diols conjugated at the 3'-end yielded such constructs, enabling selective tumor growth inhibition in an experimental in vivo situation. Further studies with complexing agents which increase their stability as well as uptake are ongoing. Another strategy aimed at obtaining strongly binding analogs, which would allow mRNA translation inhibition by steric interference. Hexitol nucleic acids (HNA) by virtue of their high and selective affinity for RNA, are therefore a prime candidate. When targeting the translation initiation regions, and using a lipofection protocol, nice activities were obtained at inhibiting Plasmodium, ICAM-1 and Ha-ras mRNA expression. Therefore, uptake should not be a limiting factor for the development of HNA as antisense therapeutics.
ISSN: 0302-6469
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Medicinal Chemistry (Rega Institute)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
3307.pdf Published 10872KbAdobe PDFView/Open Request a copy

These files are only available to some KU Leuven Association staff members


All items in Lirias are protected by copyright, with all rights reserved.